BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26788902)

  • 1. Targeted delivery of growth factors in ischemic stroke animal models.
    Rhim T; Lee M
    Expert Opin Drug Deliv; 2016; 13(5):709-23. PubMed ID: 26788902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal Delivery of Apelin-13 Is Neuroprotective and Promotes Angiogenesis After Ischemic Stroke in Mice.
    Chen D; Lee J; Gu X; Wei L; Yu SP
    ASN Neuro; 2015; 7(5):. PubMed ID: 26391329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug delivery systems for the treatment of ischemic stroke.
    Rhim T; Lee DY; Lee M
    Pharm Res; 2013 Oct; 30(10):2429-44. PubMed ID: 23307348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting vascular inflammation in ischemic stroke: Recent developments on novel immunomodulatory approaches.
    Shekhar S; Cunningham MW; Pabbidi MR; Wang S; Booz GW; Fan F
    Eur J Pharmacol; 2018 Aug; 833():531-544. PubMed ID: 29935175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice.
    Wei N; Yu SP; Gu X; Taylor TM; Song D; Liu XF; Wei L
    Cell Transplant; 2013; 22(6):977-91. PubMed ID: 23031629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroke and Drug Delivery--In Vitro Models of the Ischemic Blood-Brain Barrier.
    Tornabene E; Brodin B
    J Pharm Sci; 2016 Feb; 105(2):398-405. PubMed ID: 26869407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted delivery of neurogenin-2 protein in the treatment for cerebral ischemia-reperfusion injury.
    Deng B; Gou X; Chen H; Li L; Zhong H; Xu H; Jiang F; Zhao Z; Wang Q; Xu L
    Biomaterials; 2013 Nov; 34(34):8786-97. PubMed ID: 23942209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic Proteasome Inhibition Induces Sustained Post-stroke Neurological Recovery and Neuroprotection via Mechanisms Involving Reversal of Peripheral Immunosuppression and Preservation of Blood-Brain-Barrier Integrity.
    Doeppner TR; Kaltwasser B; Kuckelkorn U; Henkelein P; Bretschneider E; Kilic E; Hermann DM
    Mol Neurobiol; 2016 Nov; 53(9):6332-6341. PubMed ID: 26572637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opportunities and challenges: stem cell-based therapy for the treatment of ischemic stroke.
    Tang YH; Ma YY; Zhang ZJ; Wang YT; Yang GY
    CNS Neurosci Ther; 2015 Apr; 21(4):337-47. PubMed ID: 25676164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Injury and repair mechanisms in ischemic stroke: considerations for the development of novel neurotherapeutics.
    Candelario-Jalil E
    Curr Opin Investig Drugs; 2009 Jul; 10(7):644-54. PubMed ID: 19579170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transduction of neural precursor cells with TAT-heat shock protein 70 chaperone: therapeutic potential against ischemic stroke after intrastriatal and systemic transplantation.
    Doeppner TR; Ewert TA; Tönges L; Herz J; Zechariah A; ElAli A; Ludwig AK; Giebel B; Nagel F; Dietz GP; Weise J; Hermann DM; Bähr M
    Stem Cells; 2012 Jun; 30(6):1297-310. PubMed ID: 22593021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain Drug Delivery Systems for the Stroke Intervention and Recovery.
    Luo T; Wang J; Hao S; Guo T; Ren P; Cheng Z; Gao F; Gong Y; Wang B
    Curr Pharm Des; 2017; 23(15):2258-2267. PubMed ID: 27784243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia.
    Durukan A; Tatlisumak T
    Pharmacol Biochem Behav; 2007 May; 87(1):179-97. PubMed ID: 17521716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous regeneration: Engineering growth factors for stroke.
    Chan SJ; Love C; Spector M; Cool SM; Nurcombe V; Lo EH
    Neurochem Int; 2017 Jul; 107():57-65. PubMed ID: 28411103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive nitrogen species as therapeutic targets for autophagy: implication for ischemic stroke.
    Feng J; Chen X; Shen J
    Expert Opin Ther Targets; 2017 Mar; 21(3):305-317. PubMed ID: 28081644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurogenesis in Stroke Recovery.
    Koh SH; Park HH
    Transl Stroke Res; 2017 Feb; 8(1):3-13. PubMed ID: 26987852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotection targeting ischemic penumbra and beyond for the treatment of ischemic stroke.
    Liu R; Yuan H; Yuan F; Yang SH
    Neurol Res; 2012 May; 34(4):331-7. PubMed ID: 22643076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic hypothermia for acute ischemic stroke.
    Froehler MT; Ovbiagele B
    Expert Rev Cardiovasc Ther; 2010 Apr; 8(4):593-603. PubMed ID: 20397832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain ischemia as a potential target of gene therapy.
    Ooboshi H; Ibayashi S; Takada J; Kumai Y; Iida M
    Exp Gerontol; 2003; 38(1-2):183-7. PubMed ID: 12543276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.